Apply to trial NCT06243588

A few quick questions so the study team can decide if you might be a fit.

RecruitingClinical trial

Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

assess whether there is a correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma. Identification of reliable prognostic factors could help to identify high-risk patients, which may require a different treatment and follow up.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening